All Articles

CancerSEEK is a noninvasive blood test that may help detect cancer in early stages, when treatment has the highest chance for success. Read More ›

Liquid biopsy is a noninvasive blood test that can help identify cancerous cells or biomarkers, such as gene mutations that may respond to targeted therapies. Read More ›

Targeted therapies for lung cancer are newer therapies designed to target specific types of genetic mutations found in some patients, and improve the response to treatment. Read More ›

In recent years, new treatments for acute myeloid leukemia have improved outcomes. In 2017, 2 new drugs were approved for patients with this type of blood cancer linked to a specific biomarker. Read More ›

The understanding of the role of dMMR or MSI-H biomarkers in cancer has led to the first approval of a cancer drug based on a biomarker instead of a specific tumor type. Read More ›

Biomarkers are biologic markers that indicate changes in our genes and may increase the risk of cancer. Read More ›

Wenora Y. Johnson, 3-time survivor, shares her cancer story and encourages patients to ask their care team about biomarker testing. Read More ›

This first-ever direct-to-consumer genetic test can provide information on potential risks to individuals who may not have access to genetic screening, but the information may be misleading without feedback from experts. Read More ›

This is the first treatment that targets patients with AML and the FLT3-ITD mutation. In this clinical trial, patients who received quizartinib lived longer without disease progression than those receiving chemotherapy. Read More ›

May is Skin Cancer Awareness Month! View this slideshow to learn the latest statistics in the United States, leading causes and preventive measures, and quick facts on melanoma, one of the most common types of skin cancer. Conquer cancer with knowledge. Read More ›